
William A. Craigo
Examiner (ID: 17649, Phone: (571)270-1347 , Office: P/1615 )
| Most Active Art Unit | 1615 |
| Art Unit(s) | 1615 |
| Total Applications | 936 |
| Issued Applications | 383 |
| Pending Applications | 126 |
| Abandoned Applications | 445 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19682055
[patent_doc_number] => 20250000600
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-01-02
[patent_title] => GLOVE COMPRISING COATING
[patent_app_type] => utility
[patent_app_number] => 18/361506
[patent_app_country] => US
[patent_app_date] => 2023-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5512
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18361506
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/361506 | GLOVE COMPRISING COATING | Jul 27, 2023 | Pending |
Array
(
[id] => 18953437
[patent_doc_number] => 20240041764
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-08
[patent_title] => Sustained-Release Oral Fosamprenavir Formulation for Treatment of Reflux
[patent_app_type] => utility
[patent_app_number] => 18/361201
[patent_app_country] => US
[patent_app_date] => 2023-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14818
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18361201
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/361201 | Sustained-Release Oral Fosamprenavir Formulation for Treatment of Reflux | Jul 27, 2023 | Pending |
Array
(
[id] => 20006050
[patent_doc_number] => 20250144272
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-05-08
[patent_title] => CELL MATRIX NERVE GRAFT FOR REPAIRING PERIPHERAL NERVE INJURY AND PREPARATION METHOD THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/684910
[patent_app_country] => US
[patent_app_date] => 2023-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 0
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18684910
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/684910 | CELL MATRIX NERVE GRAFT FOR REPAIRING PERIPHERAL NERVE INJURY AND PREPARATION METHOD THEREOF | Jul 24, 2023 | Pending |
Array
(
[id] => 19650114
[patent_doc_number] => 12171874
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-12-24
[patent_title] => Rapamycin for the treatment of lymphangioleiomyomatosis
[patent_app_type] => utility
[patent_app_number] => 18/224560
[patent_app_country] => US
[patent_app_date] => 2023-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 21922
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18224560
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/224560 | Rapamycin for the treatment of lymphangioleiomyomatosis | Jul 19, 2023 | Issued |
Array
(
[id] => 18903222
[patent_doc_number] => 20240018707
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-18
[patent_title] => TIME-DEPENDENT SYNTHETIC BIOLOGICAL BARRIER MATERIAL
[patent_app_type] => utility
[patent_app_number] => 18/219246
[patent_app_country] => US
[patent_app_date] => 2023-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11432
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18219246
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/219246 | Time-dependent synthetic biological barrier material | Jul 6, 2023 | Issued |
Array
(
[id] => 18877438
[patent_doc_number] => 20240000807
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-04
[patent_title] => DRY SELF-EMULSIFYING CANNABINOID COMPOSITIONS AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/215458
[patent_app_country] => US
[patent_app_date] => 2023-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15846
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18215458
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/215458 | DRY SELF-EMULSIFYING CANNABINOID COMPOSITIONS AND USE THEREOF | Jun 27, 2023 | Abandoned |
Array
(
[id] => 19896894
[patent_doc_number] => 12274790
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2025-04-15
[patent_title] => Thyroid hormone oral dosage forms and methods of using the same
[patent_app_type] => utility
[patent_app_number] => 18/334408
[patent_app_country] => US
[patent_app_date] => 2023-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 6
[patent_no_of_words] => 14260
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 184
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18334408
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/334408 | Thyroid hormone oral dosage forms and methods of using the same | Jun 13, 2023 | Issued |
Array
(
[id] => 19496451
[patent_doc_number] => 20240335469
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-10
[patent_title] => READY-TO-USE PHARMACEUTICAL COMPOSITIONS OF POTASSIUM PHOSPHATES INJECTION
[patent_app_type] => utility
[patent_app_number] => 18/204475
[patent_app_country] => US
[patent_app_date] => 2023-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6942
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18204475
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/204475 | READY-TO-USE PHARMACEUTICAL COMPOSITIONS OF POTASSIUM PHOSPHATES INJECTION | May 31, 2023 | Abandoned |
Array
(
[id] => 19217815
[patent_doc_number] => 20240182519
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-06
[patent_title] => MELANOCORTIN RECEPTOR LIGANDS MODIFIED WITH HYDANTOIN
[patent_app_type] => utility
[patent_app_number] => 18/142621
[patent_app_country] => US
[patent_app_date] => 2023-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25533
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18142621
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/142621 | MELANOCORTIN RECEPTOR LIGANDS MODIFIED WITH HYDANTOIN | May 2, 2023 | Pending |
Array
(
[id] => 18739710
[patent_doc_number] => 20230348675
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-02
[patent_title] => ALGINATE HYDROGEL COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 18/310607
[patent_app_country] => US
[patent_app_date] => 2023-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16107
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18310607
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/310607 | Alginate hydrogel compositions | May 1, 2023 | Issued |
Array
(
[id] => 18565810
[patent_doc_number] => 20230256137
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-17
[patent_title] => ENCAPSULATION OF PANCREATIC CELLS DERIVED FROM HUMAN PLURIPOTENT STEM CELLS
[patent_app_type] => utility
[patent_app_number] => 18/138904
[patent_app_country] => US
[patent_app_date] => 2023-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21779
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18138904
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/138904 | ENCAPSULATION OF PANCREATIC CELLS DERIVED FROM HUMAN PLURIPOTENT STEM CELLS | Apr 24, 2023 | Abandoned |
Array
(
[id] => 19065696
[patent_doc_number] => 20240100122
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-28
[patent_title] => FORMULATIONS
[patent_app_type] => utility
[patent_app_number] => 18/136715
[patent_app_country] => US
[patent_app_date] => 2023-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 54971
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -45
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18136715
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/136715 | FORMULATIONS | Apr 18, 2023 | Abandoned |
Array
(
[id] => 18707327
[patent_doc_number] => 20230329900
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-19
[patent_title] => METHODS AND DEVICES FOR CONTROLLED DELIVERY
[patent_app_type] => utility
[patent_app_number] => 18/135523
[patent_app_country] => US
[patent_app_date] => 2023-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29761
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18135523
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/135523 | Methods and devices for controlled delivery | Apr 16, 2023 | Issued |
Array
(
[id] => 18536141
[patent_doc_number] => 20230241228
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-03
[patent_title] => Biocampatible and Biodegradable Anionic Hydrogel System
[patent_app_type] => utility
[patent_app_number] => 18/298348
[patent_app_country] => US
[patent_app_date] => 2023-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9410
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18298348
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/298348 | Biocampatible and Biodegradable Anionic Hydrogel System | Apr 9, 2023 | Pending |
Array
(
[id] => 18522923
[patent_doc_number] => 20230233573
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-27
[patent_title] => TREATING INFLUENZA USING SUBSTITUTED POLYCYCLIC PYRIDONE DERIVATIVES AND PRODRUGS THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/192491
[patent_app_country] => US
[patent_app_date] => 2023-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13798
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18192491
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/192491 | TREATING INFLUENZA USING SUBSTITUTED POLYCYCLIC PYRIDONE DERIVATIVES AND PRODRUGS THEREOF | Mar 28, 2023 | Abandoned |
Array
(
[id] => 19216423
[patent_doc_number] => 20240181127
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-06
[patent_title] => BONE SUBSTITUTE COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 18/186354
[patent_app_country] => US
[patent_app_date] => 2023-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5284
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18186354
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/186354 | Bone substitute composition | Mar 19, 2023 | Issued |
Array
(
[id] => 20022989
[patent_doc_number] => 20250161211
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-05-22
[patent_title] => LIQUID FORMULATION COMPRISING A FUSION PROTEIN INCLUDING a-GALACTOSIDASE A
[patent_app_type] => utility
[patent_app_number] => 18/832725
[patent_app_country] => US
[patent_app_date] => 2023-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10088
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18832725
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/832725 | LIQUID FORMULATION COMPRISING A FUSION PROTEIN INCLUDING a-GALACTOSIDASE A | Mar 9, 2023 | Pending |
Array
(
[id] => 19930428
[patent_doc_number] => 12303621
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-05-20
[patent_title] => Use of self-assembled alkylsilane coatings for drug delivery applications
[patent_app_type] => utility
[patent_app_number] => 18/096736
[patent_app_country] => US
[patent_app_date] => 2023-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 0
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 142
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18096736
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/096736 | Use of self-assembled alkylsilane coatings for drug delivery applications | Jan 12, 2023 | Issued |
Array
(
[id] => 18404662
[patent_doc_number] => 20230166013
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-01
[patent_title] => ANTITHROMBOTIC CELL ADHESION SHEET AND MEDICAL DEVICE WITH SHEET
[patent_app_type] => utility
[patent_app_number] => 18/154039
[patent_app_country] => US
[patent_app_date] => 2023-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5680
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18154039
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/154039 | ANTITHROMBOTIC CELL ADHESION SHEET AND MEDICAL DEVICE WITH SHEET | Jan 12, 2023 | Pending |
Array
(
[id] => 20356227
[patent_doc_number] => 12472206
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-11-18
[patent_title] => Pharmaceutical composition containing cerium compound as active ingredient
[patent_app_type] => utility
[patent_app_number] => 18/153124
[patent_app_country] => US
[patent_app_date] => 2023-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 27
[patent_no_of_words] => 15243
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18153124
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/153124 | Pharmaceutical composition containing cerium compound as active ingredient | Jan 10, 2023 | Issued |